HKD 3.05
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.53 Billion CNY | 73.38% |
2022 | 882.6 Million CNY | 99.3% |
2021 | 442.84 Million CNY | -24.88% |
2020 | 589.53 Million CNY | 152.96% |
2019 | 233.05 Million CNY | -3.5% |
2018 | 241.5 Million HKD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 1.14 Billion CNY | -24.89% |
2024 Q2 | 1.14 Billion CNY | 2.47% |
2023 Q3 | 1.37 Billion CNY | 27.13% |
2023 FY | 1.53 Billion CNY | 73.38% |
2023 Q2 | 1.08 Billion CNY | 11.75% |
2023 Q1 | 966.99 Million CNY | 9.56% |
2023 Q4 | 1.53 Billion CNY | 11.39% |
2022 Q2 | 600.43 Million HKD | 0.0% |
2022 Q3 | 749.46 Million CNY | 24.82% |
2022 Q4 | 882.6 Million CNY | 17.77% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Life Healthcare Group Limited | 5.7 Million HKD | -26713.039% |
China Biotech Services Holdings Limited | 100.39 Million HKD | -1424.184% |